AAPG: Ascentage Pharma Group International Operating Sales Margin

Graphic logo of Ascentage Pharma (AAPG)

Ascentage Pharma Group is scaling the distribution of oncology drugs in Asia while optimizing R&D costs. The operating margin trend demonstrates current business efficiency, with the indicator standing at -220.00. Patent protection for inhibitors and stringent certification requirements create a robust barrier to entry. Global partnerships with distributors minimize marketing expenses, ensuring capital and a stable cash flow.

AAPG: ascentage.com Operating Margin 01/25/2025 - 11/19/2026

Metric breakdowns and analytics for Ascentage Pharma (AAPG)

Fundamental company valuation:AAPG, Ascentage Pharma
Finished products of ascentage.com

Ascentage Pharma Group's large-scale R&D investments and the retention of leading oncologists directly impact its operating cost structure. This metric is calculated as the ratio of operating profit to revenue, demonstrating the efficiency of managing production and administrative expenses before taxes and interest. Analyzing this metric allows for an assessment of the business model's sustainability, which is clearly reflected in the operating profit margin trend.

Who Ascentage Pharma Group competes with

Operating Profitability BeiGene Ltd|Halozyme Therapeutics - Operating Profit Margin|Operating Sales Margin RVMD (Revolution Medicines Corp)|Operating Sales Margin cgoncology.com CGON|UroGen Pharma - Operating Sales Margin|Operating Profit Rate BCAX|PSNL - Operating Profitability|Profitability of Operations Erasca Oncology ERAS|delcath.com (DCTH) - Operating Profitability|Y-mAbs Therapeutics - Operating Profit Rate|AURA (Aura Biosciences Inc) - Operating Margin|Operating Return on Sales candeltx.com CADL|Operating Margin ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Operating Profit Rate|Operating Profitability Actuate Therapeutics, Inc. ACTU|citiusonc.com - Operating Profitability|TuHURA Biosciences Inc. - Operating Margin|TARA - Operating Margin|FATE (Fate Therapeutics) - Operating Sales Margin|Operating Sales Margin Aadi Bioscience, Inc.|Operating Sales Margin TCRX|Operating Profitability CSBR|Operating Margin XBIT|Profitability of Operations CEL-SCI Corp.|Operating Profitability ostherapies.com OSTX|RADX: Return on Sales by Operating Profit|ARTV: Operating Sales Margin|ANL (Adlai Nortye) - Return on Sales by Operating Profit|Veru (VERU) - Operating Profitability|Operating Sales Margin Tempest Therapeutics Inc|Operating Profitability Xilio Therapeutics|Return on Sales by Operating Profit RENB (Renovaro Inc.)|Operating Profitability Mural Oncology PLC (MURA)|Operating Margin Kairos Pharma (KAPA)|Operating Profitability onkuretherapeutics.com OKUR|GDTC: Return on Sales by Operating Profit|CRIS: Operating Sales Margin|apollomicsinc.com (APLM) - Operating Sales Margin|THAR: Operating Margin|Operating Sales Margin Advanced Biomed Inc.|Operating Sales Margin GNPX|Return on Sales by Operating Profit CLDI (Calidi Biotherapeutics)|Operating Margin SBFM|Xenetic Biosciences, Inc. - Return on Sales by Operating Profit|Operating Profitability Salarius Pharmaceuticals SLRX|Operating Margin purple-biotech.com PPBT|AONC - Operating Profitability|BGNE: Operating Profitability|CKPT: Operating Margin|Elevation Oncology - Operating Profit Rate|ICAD (iCAD) - Operating Margin|IKNA: Operating Profit Rate|Operating Profitability Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Operating Profit Rate|Operating Profitability MorphoSys Corporation MOR|NAYA: Return on Sales by Operating Profit|Ascentage Pharma Group International - Operating Margin